News
-
-
-
-
PRESS RELEASE
Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison issues review on BB Biotech (BION), highlighting its performance improvement and optimistic outlook in the recovering biotech sector, offering investors an opportunity for acquisition at an attractive level -
PRESS RELEASE
Lethally RSV Infected Animals Orally Treated with NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NanoViricides, Inc. announces strong antiviral activity of NV-387 against RSV, Influenza A, and Coronaviruses in lethal lung infection models, potentially offering a cure for RSV infection -
-
-
-
PRESS RELEASE
Total number of voting rights and capital / Information on the total number of voting rights and the number of shares making up the capital
Axway Software discloses total voting rights and shares as of April 30, 2024, in compliance with French regulations. Learn more about Axway and its offerings at investors.axway.com/en -
PRESS RELEASE
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Déclaration du nombre total de droits de vote et d’actions d'Axway Software au 30 avril 2024. Axway informe ses actionnaires des chiffres clés. A Propos d’Axway: l'entreprise aide les sociétés à ouvrir leurs ressources via des logiciels d'intégration et une plateforme de gestion des API
